Profitelligence Profitelligence · Filing Ledger Open IDXX research →

Form 8-K · Current Report · Filed 2024-11-21

IDEXX Laboratories Announces CFO Transition

IDEXX Laboratories, Inc. announced on November 20, 2024, that Brian P. McKeon, Executive Vice President, Chief Financial Officer, and Treasurer, will retire effective June 1, 2025. He will transition to the role of Executive Vice President and Special Advisor until his retirement to ensure a smooth transition. Andrew Emerson, currently Senior Vice President, Corporate and Companion Animal Group Finance, will succeed McKeon as CFO effective March 1, 2025. Emerson has been with IDEXX since 2015 and has held various finance roles, including corporate finance oversight since 2020. He will be paid an annual base salary of $550,000 and participate in the annual Executive Incentive Plan. The company also reaffirmed its 2024 full-year guidance.

Filer
Idexx Laboratories, Inc. IDXX · NASDAQ
Filed
Accession
0001104659-24-121326
CIK
0000874716
Signal
High impactHealthcare

Items reported

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

CFO Resignation New CFO Appointed
Item 7.01

Regulation FD Disclosure

Press Release Furnished
Item 9.01

Financial Statements and Exhibits

No viable tag

Market reaction

Close before filing

$418.61

Next session

-0.3%

Since filing

+33.6%

Latest close

$559.07

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from IDXX reporting the same item, with the next session's move:

Exhibits (1)

About Idexx Laboratories, Inc.

Idexx Laboratories, Inc. is a prominent player in the health technology industry, specializing in veterinary diagnostics, software, and water microbiology testing. The company develops and markets products and services that enhance animal health and well-being, offering a wide range of diagnostic tests for companion animals, livestock, and poultry. It is notably recognized for providing innovative diagnostic services including in-house analyzers and rapid assays, which facilitate quick and accurate diagnostic results for veterinarians. Besides its veterinary focus, Idexx Laboratories also provides water testing solutions aimed at ensuring the safety and quality of water supplies by identifying microbial contaminants. The firm’s advanced diagnostic technologies significantly impact the animal health sector by delivering efficient, reliable diagnostics that enable proactive animal care. Idexx stands out as a key player in enhancing laboratory efficiency through its cloud-based practice management software, improving day-to-day operations for veterinary practices worldwide. Headquartered in Westbrook, Maine, Idexx Laboratories' mission and products underscore its vital role in advancing global animal health and environmental testing solutions, making it a significant entity in the health technology market.

Exchange NASDAQ Industry Diagnostics & Research Company website ↗

Never miss another IDXX filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts